A Review of the Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors on Lean Body Mass in Humans.

Weight loss is an important goal in the management of several chronic conditions, including type 2 diabetes mellitus, and pharmacological therapies that aid weight loss are appealing. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter 2 inhibitors (SGLT2is) are novel glucose-lowering therapies that have been shown to induce clinically significant reductions in body weight. However, this weight loss may not be attributed solely to fat mass (FM).

Preventing type 2 diabetes: applying the evidence in nursing practice.

Preventing type 2 diabetes is now a public health priority. Nurses will be at the forefront of implementing and running future diabetes prevention initiatives. This article gives an overview of the evidence from evaluated diabetes prevention programmes, reviews different strategies for identifying high risk groups and highlights key strategies for communicating risk and promoting lifestyle change.